RHYTHM PHARMACEUTICALS, INC. (RYTM) Return on equity 2017–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-0.1%FY2025 · since FY2017: -23.3% → -0.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -0.1% | +1.1 pp |
| FY2024 | -1.2% | -1.1 pp |
| FY2023 | -0.1% | -0.0 pp |
| FY2022 | -0.1% | -0.0 pp |
| FY2021 | 0.0% | +80.4 pp |
| FY2020 | -80.5% | -30.4 pp |
| FY2019 | -50.1% | -20.0 pp |
| FY2018 | -30.1% | -6.8 pp |
| FY2017 | -23.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice